(Q45190838)

10 December 2017

title

Drug-eluting stents: are they really safe? (English)

1 reference

10 December 2017

2

Frank D Kolodgie

1 reference

10 December 2017

3

Andrew Farb

1 reference

10 December 2017

1

Renu Virmani

1 reference

10 December 2017

publication date

1 January 2004

1 reference

The American heart hospital journal

10 December 2017

published in

1 reference

10 December 2017

volume

2

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

85-88

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

Bringing reality to drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-9215.2004.03632.X

10.1111/J.1541-9215.2004.03632.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference